eCite Digital Repository

Do transdermal opioids affect the personal socio-economic costs of healthcare access in an Australian rural pain population? A comparison with oral opioids

Citation

Henshaw, JS and Walker, J and Geraghty, D, Do transdermal opioids affect the personal socio-economic costs of healthcare access in an Australian rural pain population? A comparison with oral opioids, Journal of Opioid Management, 8, (2) pp. 126-132. ISSN 1551-7489 (2012) [Refereed Article]


Preview
PDF
Restricted - Request a copy
328Kb
  

Copyright Statement

Copyright 2012 Weston Medical Publishing

Official URL: http://www.opioidmanagement.com/pn15006.html

DOI: doi:10.5055/jom.2012.0105

Abstract

Do transdermal opioids affect the personal socio-economic costs of healthcare access in an Australian rural pain population? A comparison with oral opioids. Objective: To determine whether there are differences in the personal socio-economic costs of healthcare access between transdermal and oral opioid use in a rural population with chronic non cancer pain (CNCP). Design: An observational longitudinal study, measuring change in the self reported personal time and expense of healthcare access by route of opioid administration over time (monthly for one year). Subjects were opioid treated CNCP patients from North West Tasmania, Australia. Subjects completed monthly datasheets by recording all personal healthcare access time and expense, together with the route(s) of opioid administration. The outcome measures of mean monthly healthcare time (MHT) and expense (MHE), by route of opioid administration were analysed using generalised estimating equations with robust standard errors. Results: The details of 10564 healthcare contacts from 198 subjects were obtained during the study. Total mean MHT with OCR opioids was 3.68hrs (95%CI = 2.11- 5.44) and unchanged (p=0.63) with TD opioids at 3.41hrs (95%CI= 2.16-4.66). Total mean MHE with oral opioids was AU$92.72 (95%CI = 51.21 to 134.24) and unchanged (p=0.81) with TD opioids at AU$89.12 (95%CI = 54.53-123.71). Conclusions: The personal socioeconomic costs of healthcare access for CNCP rural patients are similar for TD and oral opioid use. The prolonged analgesic affect of TD opioids may be advantageous for rural populations.

Item Details

Item Type:Refereed Article
Keywords:Opioids, Transdermal, Cost
Research Division:Medical and Health Sciences
Research Group:Pharmacology and Pharmaceutical Sciences
Research Field:Pharmacology and Pharmaceutical Sciences not elsewhere classified
Objective Division:Health
Objective Group:Specific Population Health (excl. Indigenous Health)
Objective Field:Rural Health
Author:Henshaw, JS (Dr John Henshaw)
Author:Geraghty, D (Professor Dominic Geraghty)
ID Code:75710
Year Published:2012
Deposited By:Health Sciences A
Deposited On:2012-02-10
Last Modified:2017-11-07
Downloads:0

Repository Staff Only: item control page